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1. General Information 
	
All reactions were performed in air. Solvents were used as received. NHC-copper(I) complexes were 
synthesized according to published procedure.[1] Azides were synthesised according to published 
procedures.[2] All other reagents were purchased and used as received. 1H, 13C-{1H} and 31P-{1H} 
Nuclear Magnetic Resonance (NMR) spectra were recorded at 298K on a Bruker AVANCE 400 
spectrometer using the residual solvent peak (CDCl3: δH = 7.26 ppm, δC = 77.16 ppm) or TMS as 
reference. Elemental analyses were performed by the London Metropolitan University Service.  
2. Synthesis and characterization of NHC-copper(I) complexes 
	
N,N’-bis-{2,6-(di-iso-propyl)phenyl}imidazol-2-ylidene-N,N’-bis{2,4,6-
(trimethyl)phenyl}imidazol-2-ylidene copper(I) tetrafluoroborate, [Cu(IPr)(IMes)]BF4, 1.[1]  
Colorless solid, 320.7 mg, 90%.  
1H NMR (400 MHz, CD2Cl2, 298K): δ (ppm): 0.82 (d, 12H, 3JHH = 6.9 Hz, CHCH3), 1.10 (d, 12H, 
3JHH = 6.9 Hz, CHCH3), 1.66 (s, 12H, CH3 Mes), 2.31 (septet, 4H, 3JHH = 6.9 Hz, CHCH3), 2.39 (s, 
6H, CH3 Mes), 6.80 (s, 4H, Ar IMes), 6.88 (s, 2H, H4 and H5), 7.11 (s, 2H, H4’ and H5’), 7.20 (d, 4H, 
3JHH = 7.8 Hz, Ar IPr), 7.57 (t, 2H, 3JHH = 7.8 Hz, Ar IPr).  
13C-{1H} NMR (75 MHz, CD2Cl2, 298K): δ (ppm): 17.3 (s, CH3 Mes), 21.3 (s, CH3 Mes), 23.6 (s, 
CHCH3), 24.5 (s, CHCH3), 28.9 (s, CHCH3), 123.9 (s, C4 and C5), 124.3 (s, C4’ and C5’), 124.5 (s, Ar  
IPr), 130.1 (s, Ar  IMes), 131.0 (s, Ar IPr), 134.5 (s, CIV), 134.6 (s, CIV), 134.8 (s, CIV), 139.6 (s, 
CIV), 145.4 (s, CIV), 176.2 (s, Ccarbene), 179.3 (s, Ccarbene).  
Anal. Calcd for C48H60BCuF4N4: C, 68.36; H, 7.17; N, 6.64. Found: C, 68.09; H, 7.24; N, 6.61. 
 
N,N’-bis-{2,6-(di-iso-propyl)phenyl}imidazol-2-ylidene-N,N’-(di-tert-butyl)imidazol-2-ylidene 
copper(I) tetrafluoroborate, [Cu(IPr)(ItBu)]BF4  2. [1] 
Colorless solid, 274 mg, 95 %.  
1H NMR (400 MHz, CD2Cl2, 298K): δ (ppm): 1.19 (s, 18H, CH3 tert-butyl), 1.22 (d, 12H, 3JHH = 
7.1 Hz, CHCH3) overlapping with 1.24 (d, 12H, 3JHH = 7.1 Hz, CHCH3), 2.71 (septet, 4H, 3JHH = 7.1 
Hz, CHCH3), 6.98 (s, 2H, H4 and H5), 7.34 (s, 2H, H4 and H5), 7.36 (d, 4H, 3JHH = 7.5 Hz, Ar IPr), 
7.54 (t, 2H, 3JHH = 7.5 Hz, Ar IPr).  
13C-{1H} NMR (CD2Cl2, 75 MHz, 298K): δ (ppm): 24.0 (s, CHCH3), 25.0 (s, CHCH3), 29.1 (s, 
CHCH3), 29.9 (s, CIV), 31.9 (s, CH3 tert-butyl), 57.3 (s, CIV mesityl), 117.6 (s, C4 and C5), 124.9 (s, 
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C4 and C5), 125.2 (s, Ar), 131.3 (s, Ar), 135.1 (s, CIV phenyl), 145.8 (s, CIV phenyl), 171.6 (s, 
Ccarbene), 179.6 (s, Ccarbene).  
Anal. Calcd for C38H56BCuF4N4: C, 63.46; H, 7.85; N, 7.79. Found: C, 63.55; H, 7.74; N, 7.82. 
 
N,N’-bis-{2,6-(di-iso-propyl)phenyl}imidazol-2-ylidene-N,N’-(dicyclohexyl)imidazol-2-ylidene 
copper(I) tetrafluoroborate, [Cu(IPr)(ICy)]BF4  3. [1] 
Colorless solid, 306 mg, 99 %.  
1H NMR (400 MHz, CD2Cl2, 298K): δ (ppm): 0.89-1.12 (m, 6H, CH2 cyclohexyl), 1.24 (d, 12H, 
3JHH = 6.8 Hz, CHCH3), 1.29 (d, 12H, 3JHH = 6.8 Hz, CHCH3), 1.31-1.42 (m, 4H, CH2 cyclohexyl), 
1.56-1.71 (m, 10H, CH2 cyclohexyl), 2.59 (septet, 4H, 3JHH = 6.8 Hz, CHCH3), 3.10 (tt, 2H, 3JHH = 
12.2 Hz, 3JHH = 4 Hz, CH cyclohexyl), 6.89 (s, 2H, H4 and H5), 7.29 (s, 2H, H4’ and H5’), 7.44 (d, 
4H, 3JHH = 7.8 Hz, Ar), 7.64 (t, 2H, 3JHH = 7.8 Hz, Ar).  
13C-{1H} NMR (CD2Cl2, 75 MHz, 298K): δ (ppm): 23.5 (s, CHCH3), 24.9 (s, CH2 cyclohexyl), 
25.1 (s, CH2 cyclohexyl), 25.7 (s, CHCH3), 29.2 (s, CHCH3), 34.5 (s, CH2 cyclohexyl), 61.3 (s, CH 
cyclohexyl), 118.6 (s, C4 and C5), 124.3 (s, C4’ and C5’), 125.0 (s, Ar), 131.6 (s, Ar), 134.6 (s, CIV), 
146.4 (s, CIV), 171.7 (s, Ccarbene), 179.3 (s, Ccarbene).  
Anal. Calcd for C42H60BCuF4N4: C, 65.40; H, 7.84; N, 7.26. Found: C, 65.37; H, 7.84; N, 7.17. 
 
(N,N’-bis-{2,6-(di-iso-propyl)phenyl}imidazole-2-ylidene)tri-tert-butylphosphine 
tetrafluoroborate copper (I) [Cu(IPr)(PtBu)3]BF4  4.[1]  
Colorless solid (294 mg, 99%).  
1H NMR (400 MHz, CD2Cl2, 298 K): δ (ppm): 1.06 (d, 27H, 3JHP  = 13.3 Hz, C(CH3)3), 1.23 (d, 
12H, 3JHH = 6.9 Hz, CHCH3), 1.28 (d, 12H, 3JHH = 6.9 Hz, CHCH3), 2.61 (septet, 4H, 3JHH = 6.9 Hz, 
CHCH3), 7.35 (d, 4H, 3JHH = 7.9 Hz, CH Ar), 7.39 (s, 2H, H4 and H5), 7.54 (t, 2H, 3JHH = 7.9 Hz, 
CH Ar).   
13C-{1H} NMR (75 MHz, CD2Cl2, 298 K): δ (ppm): 24.3 (s, CHCH3), 24.8 (s, CHCH3), 29.2 (s, 
CHCH3), 32.2 (d, 2JCP = 5.2 Hz, CH3 tert-butyl), 37.3 (d, 1JCP = 12.6 Hz, CCH3 tert-butyl), 124.6 (s, 
C4 and C5), 124.8 (s, Ar), 131.3 (s, Ar), 134.7 (s, CIV), 145.8 (s, CIV), 178.6 (d, 2JCP = 61.0 Hz, 
Ccarbene).  
31P-{1H} NMR (162 MHz, CD2Cl2, 298 K): δ (ppm): 66.9 ppm. 




3. Sulfonyl azides 
	
Tosyl azide [2] 
 
1H NMR (300 MHz, CDCl3, 298K, TMS): δ (ppm): 2.48 (s, 3H, CH3), 7.41 (d, 2H, 3JHH = 8.12 
Hz, CHAr), 7.84 (d, 2H, 3JHH = 8.12 Hz, CHAr). 
 
4-Methoxybenzenesulfonyl azide [2] 
 
1H NMR (300 MHz, CDCl3, 298K, TMS): δ (ppm): 7.06 (d, 2H, 3JHH = 9.14 Hz, CHAr), 7.90 (d, 
2H, 3JHH = 9.14 Hz, CHAr). 
 
4-Nitrobenzenesulfonyl azide [2] 
 
1H NMR (300 MHz, CDCl3, 298K, TMS): δ (ppm): 7.11 (d, 2H, 3JHH = 8.81 Hz, CHAr), 7.19 (d, 
2H, 3JHH = 8.81 Hz, CHAr). 
	
Benzenesulfonyl azide [2] 
 
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.63 (t, 2H, 3JHH = 7.7 Hz, CHAr), 7.74 (t, 1H, 
3JHH = 7.7 Hz, CHAr), 7.97 (t, 2H, 3JHH = 8.4 Hz, CHAr).  
 
Naphthalenesulfonyl azide [2] 
 
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.55-7.64 (m, 1H, CHAr), 7.65-7.70 (m, 1H, 
CHAr), 7.72-7.79 (m, 1H, CHAr), 7.99 (dd, 1H, 3JHH = 8.3, 3.1 Hz, CHAr), 8.20 (dd, 2H, 3JHH = 8.3, 
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2.9 Hz, CHAr), 8.36 (dd, 1H, 3JHH = 7.3, 3.1 Hz, CHAr), 7.50 (dd, 1H, 3JHH = 8.6, 2.9 Hz, CHAr). 
 
2,4,6-Tri-isopropyl-benzenesulfonyl azide [2] 
 
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.27 (d, 6H, 3JHH = 6.8 Hz, CH(CH3)2) 
overlapped with 1.29 (d, 12H, 3JHH = 7.0 Hz CH(CH3)2), 2.93 (septet, 1H, 3JHH = 6.8 Hz, CH(CH3)2) 
4.05 (septet, 2H, 3JHH = 7.0 Hz, CH(CH3)2), 3.82-4.07 (m, 2H, CHAr). 
 
4-Bromobenzenesulfonyl azide [2] 
	




Methanesulfonyl azide [2] 
 










4.1. Procedure for table 2 
 
A vial was charged with tosyl azide (1.00 mmol), phenylacetylene (1.05 mmol), the copper catalyst 
and solvent (1 mL - when stated). The reaction mixture was stirred at room temperature or 40°C for 
15 hours. The solvent was removed under vacuum and the conversion was determined by 1H-NMR 
based on tosyl azide.  
4.2. Procedure for Scheme 2 
	
A vial was charged with the azide (1.00 mmol), the alkyne (1.05 mmol), [Cu(IPr)(PtBu)3]BF4 4 
(37.1 mg, 5 mol%) and toluene (1 mL). The reaction mixture was stirred at room temperature for 5-
15 hours. Ethyl acetate was then added and the solution was filtered through a plug of celite. The 
solution was concentrated (0.5 mL) and hexane or diethyl ether was added (3 mL). The product was 
collected by filtration and washed with hexane or diethyl ether (2 x 3 mL). 
4.3. 1,2,3-sulfonyltriazoles 
	
1-(4-Methylbenzenesulfonyl)-4-benzene-1H-1,2,3-triazole (7aa) [3] 
 
p-Toluenesulfonyl azide (153 µL, 1.00 mmol), phenylacetylene (115 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-benzene-1H-1,2,3-triazole was obtained as a colorless solid (290 mg, 
97%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.45 (s, 3H, CH3), 7.35-7.45 (m, 5H, CHAr), 









p-Toluenesulfonyl azide (153 µL, 1.00 mmol), p-fluorophenylacetylene (110 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-(4-fluorobenzene)-1H-1,2,3-triazole was obtained as a colorless solid 
(308 mg, 97%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.45 (s, 3H, CH3), 7.12 (m, 2H, CHAr), 7.40 
(d, 2H, 3JHH = 8.2 Hz, CHAr), 7.80 (m, 2H, CHAr), 8.03 (d, 2H, 3JHH = 8.2 Hz, CHAr), 8.28 (s, 1H, N-
CH).  
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 22.0 (s, CH3),  116.3 (d,JCF = 22.5 Hz, 
CHAr), 118.8 (s, N-CH), 125.3 (d, JCF = 2.5 Hz, CIV), 128.1 (d, JCF = 6.8 Hz, CHAr), 128.9 (s, CHAr), 
130.6 (s, CHAr), 133.1 (s, CIV), 147.6 (s, CIV),  163.3 (d, JCF = 255.0 Hz, CIV).  
HRMS calcd. for C15H12FN3O2S (M+H)+ 318.0707, found 318.0707.  
1-(4-Methylbenzenesulfonyl)-4-tert-butyl-1H-1,2,3-triazole (7ac) 
 
p-Toluenesulfonyl azide (153 µL, 1.00 mmol), tert-butylacetylene (129 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-tert-butyl-1H-1,2,3-triazole was obtained as a colorless solid (274 mg, 
98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.33 (s, 9H, CCH3), 2.45 (s, 3H, CH3), 7.38 
(d, 2H, 3JHH = 8.62 Hz, CHAr), 7.80 (s, 1H, N-CH), 7.90 (d, 2H, 3JHH = 8.62 Hz, CHAr). 
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 22.0 (s, CH3), 30.1 (s, C(CH3)3), 31.1 (s, 
CIV), 118.3 (s, N-CH), 128.8 (s, CHAr), 130.5 (s, CHAr), 133.5 (s, CIV), 147.1 (s, CIV), 157.4 (s, CIV). 







p-Toluenesulfonyl azide (153 µL, 1.00 mmol), tert-butylphenylacetylene (189 µL, 1.05 mmol). 1-
(4-Methylbenzenesulfonyl)-4-(4-tert-butylbenzene)-1H-1,2,3-triazole was obtained as a colorless 
solid (348 mg, 98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.33 (s, 9H, CCH3), 2.45 (s, 3H, CH3), 7.39 
(d, 2H, 3JHH = 8.06 Hz, CHAr), 7.45 (d, 2H, 3JHH = 8.45 Hz, CHAr), 7.75 (d, 2H, 3JHH = 8.45 Hz, 
CHAr), 8.02 (d, 2H, 3JHH = 8.06 Hz, CHAr), 8.27 (s, 1H, N-CH).  
1-(4-Methylbenzenesulfonyl)-4-(2-pyridine)-1H-1,2,3-triazole (7ae)[4] 
 
p-Toluenesulfonyl azide (153 µL, 1.00 mmol), 2-ethynylpyridine (106 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-(2-pyridine)-1H-1,2,3-triazole was obtained as a colorless solid (288 mg, 
96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.48 (s, 3H, CH3), 7.21-7.32 (m, 2H, CHAr), 
7.41 (d, 2H, 3JHH = 8.2 Hz, CHAr), 7.50 (d, 1H, 3JHH = 7.6 Hz, CHAr), 7.67 (t, 1H, 3JHH = 7.6 Hz, 





p-Toluenesulfonyl azide (153 µL, 1.00 mmol), o-methoxyphenylacetylene (136 µL, 1.05 mmol). 1-
(4-Methylbenzenesulfonyl)-4-(2-methoxybenzene)-1H-1,2,3-triazole was obtained as a colorless 
solid (313 mg, 95%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.44 (s, 3H, CH3), 3.97 (s, 3H, OCH3), 6.99 
(m, 1H, CHAr), 7.06 (m, 1H, CHAr), 7.34 (m, 1H, CHAr), 7.37 (d, 2H, 3JHH = 8.4 Hz, CHAr), 8.03 (d, 
2H, 3JHH = 8.4 Hz, CHAr), 8.32 (m, 1H, CHAr), 8.57 (s, 1H, N-CH).   
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 21.9 (s, CH3), 55.6 (s, OCH3), 110.9 (s, 
CHAr), 117.8 (s, CIV), 121.1 (s, CHAr), 122.2 (s, N-CH), 128.1 (s, CHAr), 128.7 (s, CHAr), 130.0 (s, 
CHAr), 130.5 (s, CHAr),  133.5 (s, CIV), 142.9 (s, CIV), 147.2(s, CIV), 156.1 (s, CIV).  
HRMS calcd. for C16H15N3O3S (M+H)+ 330.2846, found 330.2830. 
1-(4-Methylbenzenesulfonyl)-4-(3-fluorobenzene)-1H-1,2,3-triazole (7ag) [6] 
 
p-Toluenesulfonyl azide (153 µL, 1.00 mmol), m-fluorophenylacetylene (121 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-(3-fluorobenzene)-1H-1,2,3-triazole was obtained as a colorless solid 
(305 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.46 (s, 3H, CH3), 7.07 (m, 1H, CHAr), 7.36-
7.44 (m, 3H, CHAr), 7.53-7.63 (m, 2H, CHAr), 8.04 (m, 2H, CHAr), 8.33 (s, 1H, N-CH).   




p-Toluenesulfonyl azide (153 µL, 1.00 mmol), p-methoxyphenylacetylene (136 µL, 1.05 mmol). 1-
(4-Methylbenzenesulfonyl)-4-(4-methoxybenzene)-1H-1,2,3-triazole was obtained as a colorless 
solid (306 mg, 93%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.45 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.95 
(d, 2H, 3JHH = 8.83 Hz, CHAr), 7.38 (d, 2H, 3JHH = 8.33 Hz, CHAr), 7.75 (d, 2H, 3JHH = 8.83 Hz, 
CHAr), 8.02 (d, 2H, 3JHH = 8.33 Hz, CHAr), 8.21 (s, 1H, N-CH). 
 
1-(4-Methylbenzenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole (7ai) [3,6] 
  
p-Toluenesulfonyl azide (153 µL, 1.00 mmol), 4-ethynyltoluene (133 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole was obtained as a colorless solid 
(301 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.38 (s, 3H, CH3), 2.45 (s, 3H, CH3), 7.24 (d, 
2H, 3JHH = 8.1 Hz, CHAr), 7.39 (d, 2H, 3JHH = 8.3 Hz, CHAr), 7.71 (d, 2H, 3JHH = 8.1 Hz, CHAr), 
8.03 (d, 2H, 3JHH = 8.3 Hz, CHAr), 8.27 (s, 1H, N-CH).   
1-(4-Methoxybenzenesulfonyl)-4-phenyl-1H-1,2,3-triazole (7ba) [4,5] 
 
p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), phenylacetylene (115 µL, 1.05 mmol). 1-
(4-Methoxybenzenesulfonyl)-4-phenyl-1H-1,2,3-triazole was obtained as a colorless solid (303 mg, 
96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.88 (s, 3H, OCH3), 7.03 (d, 2H, 3JHH = 8.6 
Hz, CHAr), 7.37 (m, 1H, CHAr), 7.43 (m, 2H, CHAr), 7.82 (m, 2H, CHAr),  8.08 (d, 2H, 3JHH = 8.6 





p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), p-fluorophenylacetylene (110 µL, 1.05 
mmol). 1-(4-Methoxybenzenesulfonyl)-4-(4-fluorobenzene)-1H-1,2,3-triazole product was obtained 
as a colorless solid (313 mg, 94%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.89 (s, 3H, OCH3), 7.04 (d, 2H, 3JHH = 8.8 
Hz, CH Ar), 7.12 (m, 2H, CH Ar), 7.80 (m, 2H, CHAr), 8.08 (d, 2H, 3JHH = 8.8 Hz, CHAr), 8.27 (s, 
1H, N-CH).  
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 56.1 (s, OCH3), 115.2 (s, CHAr), 116.1 
(d, JCF = 21.8 Hz, CHAr), 118.7 (N-CH), 125.3 (d, JCF = 2.4 Hz, CIV), 127.0 (s, CIV), 128.1 (d, JCF = 
8.9 Hz, CHAr), 131.3 (s, CHAr), 146.5 (s, CIV), 163.3 (d, JCF = 254 Hz, CIV), 165.6 (s, CIV). 
HRMS calcd. for C15H12FN3O3S (M+H)+ 334.0656, found 334.0661. 
1-(4-Methoxybenzenesulfonyl)-4-(4-tert-butylbenzene)-1H-1,2,3-triazole (7bd) 
 
p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), p-tert-butylphenylacetylene (189 µL, 1.05 
mmol). 1-(4-Methoxybenzenesulfonyl)-4-(4-tert-butylbenzene)-1H-1,2,3-triazole product was 
obtained as a colorless solid (364 mg, 98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.34 (s, 9H, CCH3), 3.89 (s, 3H, OCH3), 7.03 
(d, 2H, 3JHH = 9.13 Hz, CHAr), 7.45 (d, 2H, 3JHH = 8.3 Hz, CHAr), 7.75 (d, 2H, 3JHH = 8.3 Hz, CHAr), 
8.08 (d, 2H, 3JHH = 9.13 Hz, CHAr), 8.26 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 31.4 (s, CCH3), 34.9 (s, CIV), 56.1 (s, 
OCH3), 115.2 (s, CHAr), 118.6 (s, N-CH), 126.0 (s, CHAr), 126.0 (s, CHAr), 126.2 (s, CIV), 127.2 (s, 
CIV), 131.3 (s, CHAr), 147.4 (s, CIV), 152.4 (s, CIV), 165.5 (s, CIV).  





p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), o-methoxyphenylacetylene (136 µL, 1.05 
mmol). 1-(4-Methoxybenzenesulfonyl)-4-(2-methoxybenzene)-1H-1,2,3-triazole was obtained as a 
colorless solid (332 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.84 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.95 
(d, 2H, 3JHH = 8.8 Hz, CHAr), 7.03  (d, 2H, 3JHH = 9.1 Hz, CHAr), 7.75 (d, 2H, 3JHH = 8.8 Hz, CHAr), 
8.07 (d, 2H, 3JHH = 9.1 Hz, CHAr), 8.21 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 55.5 (s, OCH3), 56.1 (s, OCH3), 114.5 (s, 
CHAr), 115.2 (s, CHAr), 118.0 (N-CH), 121.6 (s, CIV), 127.2 (s, CIV), 127.5 (s, CHAr), 131.3 (s, 
CHAr), 147.3 (s, CIV), 160.4 (s, CIV), 165.4 (s, CIV).  
HRMS calcd. for C16H15N3O4S (M+H)+ 346.0856, found 346.0851.  
1-(4-methoxybenzenesulfonyl)-4-(3-fluorobenzene)-1H-1,2,3-triazole (7bg) 
 
p-Methoxybenzenesulfonyl azide (213 µL, 1.00 mmol), m-fluorophenylacetylene (121 µL, 1.05 
mmol). 1-(4-Methoxybenzenesulfonyl)-4-(3-fluorobenzene)-1H-1,2,3-triazole was obtained as a 
colorless solid ( 320 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.89 (s, 3H, OCH3), 7.02-7.12 (m, 3H, CHAr), 
7.40 (m, 1H, CHAr), 7.58 (m, 2H, CHAr), 8.09 (m, 2H, CHAr), 8.32 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 56.1 (s, OCH3),  113.3 (d, JCF = 22.5 Hz, 
CHAr), 115.3 (s, CHAr), 116.1 (d, JCF = 21.8 Hz, CIV), 119.4 (s, N-CH), 121.8 (d, JCF = 2.6 Hz, 
CHAr), 126.9 (s, CIV), 130.9 (d, JCF = 8.7 Hz, CHAr), 131.5 (s, CHAr), 165.6 (s, CIV).  





p-Methoxybenzenesulfonyl azide (213.2 mg, 1.00 mmol), 4-ethynylanisole (136.2 µL, 1.05 mmol). 
1-(4-Methoxybenzenesulfonyl)-4-(4-methoxybenzene)-1H-1,2,3-triazole was obtained as a 
colorless solid ( 328.1 mg, 95%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.84 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 6.96 
(d, 2H, 3JHH = 7.9 Hz, CHAr), 7.04 (d, 2H, 3JHH = 8.6 Hz, CHAr), 7.75 (d, 2H, 3JHH = 7.9 Hz, CHAr), 
8.08 (d, 2H, 3JHH = 8.6 Hz, CHAr), 8.22 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 55.5 (s, OCH3), 56.1 (s, OCH3), 114.5 (s, 
CHAr), 115.2 (s, CHAr), 118.0 (N-CH), 121.7 (s, CIV), 127.2 (s, CIV), 127.6 (s, CHAr), 131.3 (s, 
CHAr), 160.4 (s, CIV), 165.4 (s, CIV).  
HRMS calcd. for C16H15N3O4S (M+H)+ 346.056, found 346.0860.   
1-(4-Methoxybenzenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole (7bi) 
 
p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), 4-ethynyltoluene (133 µL, 1.05 mmol). 1-
(4-Methoxybenzenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole was obtained as a colorless 
solid ( 316 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.38 (s, 3H, CH3), 3.88 (s, 3H, OCH3), 7.03 
(d, 2H, 3JHH = 8.92 Hz, CHAr), 7.24  (d, 2H, 3JHH = 7.64 Hz, CHAr), 7.71 (d, 2H, 3JHH = 7.64 Hz, 
CHAr), 8.08 (d, 2H, 3JHH = 8.92 Hz, CHAr), 8.26 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 21.5 (s, CH3), 56.1 (s, OCH3), 115.2 (s, 
CHAr), 118.5 (s, N-CH), 126.1 (s, CHAr), 126.2 (s, CIV), 127.2 (s, CIV), 129.8 (s, CHAr), 131.3 (s, 
CHAr), 139.2 (s, CIV), 147.5 (s, CIV), 165.5 (s, CIV).  
HRMS calcd. for C16H15N3O3S (M+H)+ 330.0907, found 330.0912.   
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1-(4-Methoxybenzenesulfonyl)-4-(3,5-trifluoromethylbenzene)-1H-1,2,3-triazole (7bj) [4] 
 
p-Methoxybenzenesulfonyl azide (213 mg, 1.00 mmol), 3,5-bis(trifluoromethyl)-phenylacetylene 
(186 µL, 1.05 mmol). 1-(4-Methoxybenzenesulfonyl)-4-(3,5-bis(trifluoromethyl)benzene)-1H-
1,2,3-triazole product was obtained as a colorless solid (415 mg, 92%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.90 (s, 3H, OCH3), 7.06 (d, 2H, 3JHH = 9.1 
Hz, CHAr), 7.87 (s, 1H, CHAr), 8.11 (d, 2H, 3JHH = 9.1 Hz, CHAr), 8.28 (s, 2H, CHAr), 8.47 (s, 1H, 
N-CH).   
1-(Methylsulfonyl)-4-benzene-1H-1,2,3-triazole (7ca) [5, 6] 
 
Methylsulfonyl azide (121 mg, 1.00 mmol), phenylacetylene (115 µL, 1.05 mmol). 1-
(Methysulfonyl)-4-benzene-1H-1,2,3-triazole product was obtained as a colorless solid (216 mg, 
97%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 3.00 (s, 3H, CH3), 7.52 (m, 3H, CHAr), 7.86  
(m, 2H, CHAr), 8.37 (s, 1H, CHAr).    
1-(Naphthalenesulfonyl)-4-benzene-1H-1,2,3-triazole (7da) [4, 6] 
 
Naphthalenesulfonyl azide (233 mg, 1.00 mmol), phenylacetylene (115 µL, 1.05 mmol). 1-




1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.36-7.46 (m, 3H, CHAr), 7.61-7.84 (m, 5H, 
CHAr), 7.97 (d, 1H, 3JHH = 8.52 Hz, CHAr), 8.24 (d, 1H, 3JHH = 8.91 Hz, CHAr), 8.41 (s, 1H, NCH),  
8.66  (d, 1H, 3JHH = 8.52 Hz, CHAr), 8.88  (d, 1H, 3JHH = 8.91 Hz, CHAr). 
1-(Naphthalenesulfonyl)-4-(4-fluorobenzene)-1H-1,2,3-triazole (7db) 
 
Naphthalenesulfonyl azide (233 mg, 1.00 mmol), p-fluorolphenylacetylene (110 µL, 1.05 mmol). 1-
(Naphtalenesulfonyl)-4-(4-fluorobenzene)-1H-1,2,3-triazole was obtained as a colorless solid ( 332 
mg, 94% with 10mol% of catalyst ).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.11 (t, 2H, 3JHH = 8.6 Hz, CHAr), 7.61-7.85 
(m, 5H, CHAr), 7.97 (d, 1H, 3JHH = 8.2 Hz, CHAr), 8.24  (d, 1H, 3JHH = 8.2 Hz, CHAr), 8.37 (s, 1H, 
NCH),  8.65  (dd, 1H, 3JHH = 7.6, 1.2 Hz, CHAr), 8.87 (dd, 1H, 3JHH = 8.6, 1.2 Hz, CHAr) . 
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 116.2 (d, JCF = 21.7 Hz, CHAr), 118.9 (s, 
N-CH), 124.3 (s, CHAr), 127.9 (s, CHAr), 128.0(s, CIV), 128.1 (s, CIV), 128.5 (s, CIV), 129.7 (d, JCF = 
8.9 Hz, CHAr), 131.2 (s, CIV), 132.5 (s, CHAr), 134.4 (s, CHAr), 137.9 (s, CHAr). 
HRMS calcd. for C18H12FN3O2S (M+H)+ 354.0707, found 354.0710.  
1-(Naphthalenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole (7di) 
 
Naphtalenesulfonyl azide (233 mg, 1.00 mmol), p-methylphenylacetylene (106 µL, 1.05 mmol). 1-
(Naphtalenesulfonyl)-4-(4-methylbenzene)-1H-1,2,3-triazole obtained as a colorless solid ( 325 mg, 
93%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 2.36 (s, 3H, CH3), 7.22 (m, 2H, CHAr), 7.69  
(m, 5H, CHAr), 7.95 (m, 1H, CHAr), 8.22 (m, 1H, CHAr), 8.36 (m, 1H, N-CH), 8.64 (m, 1H, CHAr),  
8.87 (s, 1H, CHAr).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 21.5 (s, CH3), 118.7 (s, N-CH), 124.2 (s, 
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CHAr), 124.4 (s, CHAr), 126.1 (s, CHAr), 127.9 (s, CHAr), 128.5 (s, CIV), 129.8 (s, CHAr),129.5  (s, 
CHAr), 131.4 (s, CIV), 132.4  (s, CHAr), 134.4 (s, CIV), 137.8  (s, CHAr), 139.3 (s, CIV), 147.6 (s, CIV). 
HRMS calcd. for C19H15N3O2S (M+H)+ 350.0958, found 350.0962.  
1-Benzenesulfonyl-4-benzene-1H-1,2,3-triazole (7ea) [5] 
 
Benzenesulfonyl azide (183 mg, 1.00 mmol), phenylacetylene (110 µL, 1.05 mmol). 1-
Benzenesulfonyl)-4-benzene-1H-1,2,3-triazole product was obtained as a colorless solid (277  mg, 
97%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.33 (s, 1H, CHAr), 7.44 (t, 2H, 3JHH = 7.7 Hz, 
CHAr), 7.62 (t, 2H, 3JHH = 7.6 Hz, CHAr), 7.74 (t, 3H, 3JHH = 7.6 Hz, CHAr), 7.83 (d, 2H, 3JHH = 8.0 
Hz, CHAr), 8.16 (d, 2H, 3JHH = 8.0 Hz, CHAr), 8.33 (s, 1H, N-CH). 
1-Benzenesulfonyl-4-fluorobenzene-1H-1,2,3-triazole (7eb) 
 
Benzenesulfonyl azide (183 mg, 1.00 mmol), p-fluorophenylacetylene (110 µL, 1.05 mmol). 1-
(Benzenesulfonyl)-4-(4-fluorobenzene)-1H-1,2,3-triazole product obtained as a colorless solid ( 285 
mg, 94%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.13 (m, 2H, CHAr), 7.62 (m, 2H, CHAr), 7.70-
7.86 (d, 3H, CHAr), 8.16 (d, 2H, 3JHH = 8.0 Hz, CHAr), 8.29 (s, 1H, N-CH).   
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 116.1 (d, JCF = 22.3Hz, CHAr), 118.9 (N-
CH), 125.0 (s, CIV), 122.8 (d, JCF = 8.4 Hz, CHAr), 128.8 (s, CHAr), 130.0 (s, CHAr), 135.9 (s, CIV). 





Benzenesulfonyl azide (183 mg, 1.00 mmol), tert-butylphenylacetylene (189 µL, 1.05 mmol). 1-(4-
Methylbenzenesulfonyl)-4-(4-tert-butylbenzene)-1H-1,2,3-triazole product was obtained as a 
colorless solid (328 mg, 96% with 10 mol%  of catalyst).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.34 (s, 9H, CCH3), 7.46 (d, 2H, 3JHH = 8.26 
Hz, CHAr), 7.61 (m, 2H, CHAr), 7.74 (m, 2H, CHAr), 8.15 (d, 2H, 3JHH = 8.26 Hz, CHAr), 8.29 (s, 1H, 
N-CH). 
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 31.4 (s, CH3), 34.9 (s, C(CH3)3), 118.8 
(s, N-CH), 126.0 (s, CHAr), 126.1 (s, CHAr), 126.8 (s, CIV), 128.8 (s, CHAr), 129.9 (s, CHAr), 135.8 
(s, CIV), 136.4 (s, CIV), 152.6 (s, CIV).  
HRMS calcd. for C18H19FN3O2S (M+H)+ 342.1271, found 342.1269.   
1-Benzenesulfonyl-3-fluorobenzene-1H-1,2,3-triazole (7eg) 
 
Benzenesulfonyl azide (183 mg, 1.00 mmol), 3-fluorophenylacetylene (121 µL, 1.05 mmol). 1-
Benzenesulfonyl-3-fluorobenzene-1H-1,2,3-triazole product was obtained as a colorless solid ( 297 
mg, 98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.07 (tdd, 1H, 3JHH = 1 Hz, 2.5 Hz, 8.0 Hz, 
CHAr), 7.41 (m, 1H, CHAr), 7.54 - 7.67 (m, 4H, CHAr), 7.75 (tt, 1H , 3JHH = 1.8 Hz, 7.5 Hz, CHAr), 
8.17 (m, 2H, CHAr), 8.34 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 113.3 (d, JCF = 23.6 Hz, CHAr), 116.2 (d, 
JCF = 21 Hz, CHAr), 119.6 (s, N-CH),121.9 (d, JCF = 2.5 Hz, CHAr), 128.9 (s, CHAr), 130.1 (s, 
CHAr), 130.8 (s, d, JCF = 8.5 Hz, CHAr), 136.0 (s, CHAr), 136.2 (s, CIV), 155.2 (s, CIV), 164.5 (d, JCF 





Benzenesulfonyl azide (183 mg, 1.00 mmol), p-methoxyphenylacetylene (136 µL, 1.05 mmol). 1-
(Benzenesulfonyl)-4-(4-methoxybenzene)-1H-1,2,3-triazole product was obtained as a colorless 
solid (309 mg, 98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ = 3.84 (s, 3H, OCH3), 6.95 (m, 2H, CHAr), 7.60 (m, 
2H, CHAr), 7.73 (m, 1H, CHAr) overlapped with 7.76 (m, 2H, CHAr), 8.15 (m, 2H, CHAr), 8.23 (s, 
1H, N-CH).   
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 55.5 (s, OCH3), 114.6 (s, CHAr), 118.1 
(N-CH), 121.5 (s, CIV), 127.6 (s, CHAr), 128.8 (s, CHAr), 130.0 (s, CHAr), 135.8 (s, CHAr), 136.4 (s, 
CIV), 147.5 (s, CIV), 160.5 (s, CIV). 
HRMS calcd. for C15H13FN3O3S (M+H)+ 316.0750, found  316.0750. 
1-(2,4,6-Tri-iso-propyl-benzenesulfonyl)-4-benzene-1H-1,2,3-triazole (7fa) [8] 
 
2,4,6-Tri-iso-propyl-benzenesulfonyl azide (309 mg, 1.00 mmol), phenylacetylene (115 µL, 1.05 
mmol). 1-(2,4,6-Tri-iso-propyl-benzenesulfonyl)-4-benzene-1H-1,2,3-triazole product was obtained 
as a colorless solid ( 403 mg, 98%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.25 (m, 18H, CHCH3), 2.92 (m, 1H, 
CHCH3), 4.18 (m, 2H, CHCH3), 7.36-7.56 (m, 5H, CHAr), 7.87 (m, 2H, CHAr), 8.40 (s, 1H, N-CH).   
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1-(4-Bromobenzenesulfonyl)-4-benzene-1H-1,2,3-triazole (7ga) [5] 
 
p-Bromobenzenesulfonyl azide (262 mg, 1.00 mmol), phenylacetylene (115  µL, 1.05 mmol). 1-(4-
Bromobenzenesulfonyl)-4-benzene-1H-1,2,3-triazole was obtained as a colorless solid (335 mg, 
92%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.44 (m, 3H, CHAr), 7.76 (m, 2H, CHAr), 7.83 
(m, 2H, CHAr), 8.02 (m, 2H, CHAr), 8.31 (s, 1H, N-CH).   
1-(4-Bromobenzenesulfonyl)-4-(tert-butylmethylbenzene)-1H-1,2,3-triazole (7gd) 
 
p-Bromobenzenesulfonyl azide (262.1 mg, 1.00 mmol), 4-tert-butylphenylacetylene (189 µL, 1.05 
mmol). 1-(4-Bromobenzenesulfonyl)-4-(4-tert-butyl-methylbenzene)-1H-1,2,3-triazole was 
obtained as a colorless solid (411.9 mg, 98% with 10 mol% of catalyst).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 1.34 (s, 9H, CCH3), 7.46 (m, 2H, CHAr), 7.75 
(m, 4H, CHAr), 8.00 (s, 2H, CHAr), 8.27 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 31.4 (s, CCH3), 34.9 (s, CCH3), 118.7 (s, 
N-CH), 125.8 (s, CHAr), 126.0 (s, CHAr), 126.1 (s, CHAr), 130.1 (s, CHAr), 131.6 (s, CIV), 133.4 (s, 
CIV), 135.3 (s, CIV), 152.7 (s, CIV).  






p-Bromobenzenesulfonyl azide (262 mg, 1.00 mmol), m-fluorophenylacetylene (121 µL, 1.05 
mmol). 1-(4-Bromobenzenesulfonyl)-4-(3-fluorobenzene)-1H-1,2,3-triazole was obtained as a 
colorless solid (375 mg, 98% with 10 mol% of catalyst).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.09 (d, 1H, CHAr), 7.41 (s, 1H, CHAr), 7.53-
7.62 (m, 2H, CHAr), 7.77 (m, 2H, CHAr), 8.02 (s, 2H, CHAr), 8.32 (s, 1H, N-CH).    
1-(4-Bromobenzenesulfonyl)-4-(3,5-trifluoromethylbenzene)-1H-1,2,3-triazole (7gj) 
 
p-Bromobenzenesulfonyl azide (262 mg, 1.00 mmol), 3,5-trifluorometylphenylacetylene (186 µL, 
1.05 mmol). 1-(4-Bromobenzenesulfonyl)-4-(3,5-trifluoromethylbenzene)-1H-1,2,3-triazole product 
was obtained as a colorless solid (480 mg, 96%).  
1H NMR (400 MHz, CDCl3, 298K, TMS): δ (ppm): 7.79 (d, 2H, 3JHH = 8.9 Hz, CHAr), 7.89 (s, 1H, 
CHAr), 8.04 (d, 2H, 3JHH = 8.9 Hz, CHAr), 8.29 (s, 2H, CHAr), 8.49 (s, 1H, N-CH).    
13C-{1H} NMR (75 MHz, CDCl3, 298K, TMS): δ (ppm): 120.4 (N-CH), 122.8 (s, CHAr), 123.2 (q, 
JCF = 275.0 Hz, CIV), 126.3 (s, CHAr), 130.3 (s, CHAr), 131.1 (s, CIV),  132.4 (q, JCF = 34 Hz, CIV) 
133.6 (s, CHAr), 134.7 (s, CIV), 144.9 (s, CIV).  







5. Optimization  
5.1. Comparison of complexesa 
	


















ItBu RT 10 toluene 30 

















ICy RT 10 water 30 











































































































IMes RT 10 THF 0 
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IMes RT 10 Acetonitrile 14 
























































































a Reaction conditions: azide (1.00 mmol), alkyne (1.05 mmol), solvent (0.5 mL). b Conversion 
determined by 1H-NMR, minimum average of 2 reactions. EtOAc = ethyl acetate, THF = 








5.2. Comparison between the [Cu(IPr)(PtBu3)] and the bis-carbene copper (I) 
complexes at lower loading 
	


















ItBu RT 5 toluene 30 









ICy RT 5 water 40 



































PtBu3 RT 5 THF 20 
PtBu3 RT 5 Dioxane 20 
a Reaction conditions: azide (1.00 mmol), alkyne (1.05 mmol), solvent (0.5 mL). b Conversion 





6. NMR spectra  






















































































6.2. NMR Spectra of catalysis products  
 
Compound 7aa 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A mixture of [Cu(IPr)(PtBu3)] 4 and phenylacetylene was stirred overnight in acetonitrile at RT. 
The solvent was removed in vacuo and toluene was added. The precipitate (B) was collected by 
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